Int J Clin Oncol. 2022 Dec 19. doi: 10.1007/s10147-022-02258-x. Online ahead of print.
NO ABSTRACT
PMID:36534262 | DOI:10.1007/s10147-022-02258-x
Categories
Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial
